Related Experiment Video
Updated: Mar 21, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.2K
A 10-Year Patterns of Use Analysis for the World's First Commercial Compact Pencil Beam Scanning Proton Therapy
Yohan A Walter1, Hsinshun T Wu2, Michael Durci2
1Department of Radiation Oncology, Willis Knighton Cancer Center, Shreveport, Louisiana; Clinical Research Department, University of Jamestown, Fargo, North Dakota.
Summary
This study shows that compact pencil beam scanning proton therapy (PBS-PBT) is feasible and sustainable in community hospitals. Despite global challenges, PBS-PBT use remained stable, with hypofractionation reducing treatment burden.
Area of Science:
- Oncology
- Medical Physics
- Radiation Therapy
Background:
- Miniaturization of treatment delivery systems has democratized pencil beam scanning proton therapy (PBS-PBT).
- The first commercial compact PBS-PBT system was installed in September 2014 at a community health center.
- This study details the ten-year experience with this pioneering system.
Purpose of the Study:
- To evaluate the clinical feasibility and utilization trends of the world's first compact PBS-PBT system over a decade.
- To assess the impact of external factors, such as the COVID-19 pandemic, on PBS-PBT treatment delivery.
- To analyze patient demographics, treatment sites, and fractionation patterns.
Main Methods:
- Review of patient records for those initiating PBS-PBT between September 2014 and September 2024.
- Collection of demographic and treatment planning data for each treatment course.
- Application of Pearson correlation to identify trends in fractionation over time.
Main Results:
- A total of 1382 PBS-PBT courses were initiated over ten years, with an average of 138.2 courses annually.
- Prostate and brain were the most frequently treated sites. Reirradiation and stereotactic ablative radiation therapy (SABR) settings were utilized.
- Pearson correlation revealed a significant decrease in fractionation over time (r=-0.25, p<0.01), with nearly 90% of patients residing within a 100-mile radius.
Conclusions:
- The compact PBS-PBT system demonstrated stable utilization patterns and longevity in a community hospital setting, even during the COVID-19 pandemic.
- Hypofractionation trends have reduced treatment duration and potential financial toxicity for patients.
- Continued evidence generation and supportive health policies are expected to drive further expansion of PBS-PBT indications.

